Skip to content
10-Q

Quarterly Report

BARINTHUS BIOTHERAPEUTICS PLC BRNS

0001828185-25-000037

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 40.34M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $99.12M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $110.66M
Stockholders Equity Q1 2025 · Mar 31, 2025 $115.49M
Stockholders Equity Q1 2025 · Dec 31, 2024 $130.03M
Current Liabilities Q1 2025 · Mar 31, 2025 $11.98M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.66M
Total Liabilities Q1 2025 · Mar 31, 2025 $26.4M
Total Liabilities Q1 2025 · Dec 31, 2024 $30.19M
Current Assets Q1 2025 · Mar 31, 2025 $109.88M
Current Assets Q1 2025 · Dec 31, 2024 $125.74M
Total Assets Q1 2025 · Mar 31, 2025 $142M
Total Assets Q1 2025 · Dec 31, 2024 $160.33M
Shares Diluted Q1 2025 · Mar 31, 2024 38.77M sh
Capex Q1 2025 · Mar 31, 2024 $308K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$11.82M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.40
Eps Basic Q1 2025 · Mar 31, 2024 −$0.40
Sga Expense Q1 2025 · Mar 31, 2024 $5.99M
Rd Expense Q1 2025 · Mar 31, 2024 $11.13M
Net Income Q1 2025 · Mar 31, 2024 −$15.49M
Operating Income Q1 2025 · Mar 31, 2024 −$16.91M